Europe Facial Aesthetics Market Size, Share & Industry Trends Analysis Report By Product (Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels), By Application, By End User, By Country and Growth Forecast, 2022 - 2028

The Europe Facial Aesthetics Market is expected to witness market growth of 14.2% CAGR during the forecast period (2022-2028).

Botulinum toxin promotes young people to have such facial aesthetic procedures by reducing fine lines and wrinkles on the face. Furthermore, a variety of procedures include lip augmentation, regaining facial volume, and facial rejuvenation using facial aesthetics. Additionally, skin lightning, enhancing skin texture, and repairing facial wrinkles are done using whole field ablative, photo rejuvenation, and micro-ablative resurfacing.

As people age, their skin begins to lose its natural elasticity, leaving it looking dry and drab. However, there are a few facial cosmetic procedures that can help patients revive their skin, and apart from this, patients can get these procedures done at nearby their homes owing to the large availability of clinics and spas offering this type of service. Cosmetic procedures called facial aesthetics accentuate the inherent beauty and draw attention to the facial traits.

In recent decades, spa tourism has experienced significant development, actively embracing wellbeing and wellness. According to the National Library of Medicine, since there are over 300 spas in Germany and they collectively account for 30% of the total nights spent at German tourist locations, health tourism is essential to the German economy. It has an annual revenue of around US $36.4 billion and employs about 350,000 Germans directly or indirectly. These figures demonstrate that one of the most significant segments of the German tourism industry is healthcare and spas.

The Germany market dominated the Europe Facial Aesthetics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $989.9 million by 2028. The UK market is anticipated to grow at a CAGR of 13.3% during (2022 - 2028). Additionally, The France market is expected to exhibit a CAGR of 15.1% during (2022 - 2028).

Based on Product, the market is segmented into Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels, and Others. Based on Application, the market is segmented into Facial line correction treatment, Scar treatment, Lip enhancement, Restoration of volume or Fullness, and Others. Based on End User, the market is segmented into Hospitals, Specialty & Dermatology Clinics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Candela Medical Corporation (Syneron Medical Ltd.), Teoxane S.A., Johnson & Johnson, Cynosure, LLC, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, and Fotona D.o.o.

Scope of the Study

Market Segments Covered in the Report:

By Product

• Dermal fillers
• Botulinum toxin
• Microdermabrasion
• Chemical peels
• Others

By Application

• Facial line correction treatment
• Scar treatment
• Lip enhancement
• Restoration of volume or Fullness
• Others

By End User

• Hospitals
• Specialty & Dermatology Clinics
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• AbbVie, Inc.
• Merz Pharma GmbH & Co. KGaA
• Galderma S.A.
• Candela Medical Corporation (Syneron Medical Ltd.)
• Teoxane S.A.
• Johnson & Johnson
• Cynosure, LLC
• Bausch Health Companies, Inc.
• Ipsen Pharma Biotech SAS
• Fotona D.o.o.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free